Procaps Group Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jose Antonio Vieira

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	n/a
Durata media del management	4.5yrs
Durata media del Consiglio di amministrazione	1.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Jose Antonio Vieira (58 yo)

less than a year

Mandato

Mr. Jose Antonio Toledo Vieira is Chief Executive Officer of Procaps Group S.A. from January 15, 2024. He has been Member of Advisory Board at Patria Latin American Opportunity Acquisition Corp. since 2022...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Jose Antonio Vieira	Chief Executive Officer	less than a year	Nessun dato	Nessun dato
Patricio Munoz	Global Chief Financial Officer	3.3yrs	Nessun dato	Nessun dato
Camilo Camacho	Chief Operations Officer	no data	Nessun dato	Nessun dato
Melissa Angelini	Investor Relations Director	2.8yrs	Nessun dato	Nessun dato
Marcela Pagano	Vice-President of Corporate & Legal Affairs	11.8yrs	Nessun dato	Nessun dato
Luis Alberto Aragon	Vice-President of International Marketing and R&D	5.8yrs	Nessun dato	Nessun dato
Mauricio Caballero	Vice-President of Human Resources	10.3yrs	Nessun dato	Nessun dato

4.5yrs

Durata media

54yo

Età media

Gestione esperta: Il team dirigenziale di 9X1 è considerato esperto (durata media dell'incarico 4.5 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Daniel Fink	Board Observer	1.8yrs	Nessun dato	Nessun dato
Jose Gontovnik	Chairman	less than a year	Nessun dato	15.92% € 11.8m
Kyle Bransfield	Independent Director	3.2yrs	Nessun dato	1.81% € 1.3m
David Yanovich Wancier	Independent Director	no data	Nessun dato	Nessun dato
Alberto Eguiguren Correa	Independent Director	1.8yrs	Nessun dato	Nessun dato
Luis Castro Vergara	Independent Director	no data	Nessun dato	Nessun dato
Sandra Sanchez Oldenhage	Independent Director	1.1yrs	Nessun dato	Nessun dato
Roberto Albisetti	Independent Director	less than a year	Nessun dato	Nessun dato

1.4yrs

Durata media

55yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 9X1 non è considerato esperto (durata media del mandato 1.4 anni), il che suggerisce un nuovo consiglio.

Procaps Group Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

High number of new directors

Procaps Group S.A. Announces Resignation of Ruben Minski as Board of Directors

High number of new directors

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Recent updates

New minor risk - Market cap size

High number of new directors

Investor sentiment deteriorates as stock falls 20%

Investor sentiment improves as stock rises 19%

Procaps Group S.A. Announces Resignation of Ruben Minski as Board of Directors

Investor sentiment deteriorates as stock falls 17%

Hoche Partners Raises Concerns on Shareholder Letter Issued by Procaps Group

High number of new directors

Hoche Partners Criticizes Procaps Group's Majority Shareholder for Mismanagement and Rejection of Financial Restructuring Offer

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. announced delayed 20-F filing

Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023

Investor sentiment deteriorates as stock falls 17%

Investor sentiment improves as stock rises 21%

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Investor sentiment deteriorates as stock falls 23%

New major risk - Revenue and earnings growth

Hoche Partners Sends a Letter to Procaps Group

Hoche Partners Sends a Letter to Procaps Group

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: US$0.08 (vs US$0.22 in 3Q 2022)

Investor sentiment improves as stock rises 26%

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. to Report Q3, 2023 Results on Nov 14, 2023

Investor sentiment deteriorates as stock falls 17%

Investor sentiment improves as stock rises 23%

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Investor sentiment deteriorates as stock falls 20%

Second quarter 2023 earnings released: EPS: US$0.27 (vs US$0.068 loss in 2Q 2022)

New major risk - Earnings quality

Procaps Group S.A. to Report Q2, 2023 Results on Sep 05, 2023

Procaps Group S.A., Annual General Meeting, Jun 30, 2023

Procaps Group S.A. to Report Q1, 2023 Results on Jun 05, 2023

Full year 2022 earnings released: EPS: US$0.42 (vs US$1.03 loss in FY 2021)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 25%

Now 22% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Less than half of directors are independent

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. (NasdaqGM:PROC) announces an Equity Buyback for 2,000,000 shares, for $5 million.

Investor sentiment deteriorates as stock falls 19%

Now 23% undervalued after recent price drop

Procaps Group Announces Key Changes to the Board of Directors

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.22 (vs US$1.14 loss in 3Q 2021)

Procaps Group S.A. to Report Q3, 2022 Results on Nov 14, 2022

Second quarter 2022 earnings released: US$0.07 loss per share (vs US$0.01 loss in 2Q 2021)

Now 20% undervalued after recent price drop

Procaps Group S.A., Annual General Meeting, Jun 28, 2022

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Full year 2021 earnings released: US$1.03 loss per share (vs US$5.22 loss in FY 2020)

Forecast to breakeven in 2022

Now 21% undervalued after recent price drop

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

Procaps Group, S.A. (NasdaqGM:PROC) acquired 86,000 sq. ft. Pharmaceutical Production Facility Located in West Palm Beach, Florida from Strides Pharma Inc.

Less than half of directors are independent

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media